SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-154262
Filing Date
2024-06-04
Accepted
2024-06-04 16:15:01
Documents
13
Period of Report
2024-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d844498d8k.htm   iXBRL 8-K 34312
  Complete submission text file 0001193125-24-154262.txt   162300

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crgx-20240603.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20240603_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20240603_pre.xml EX-101.PRE 11701
16 EXTRACTED XBRL INSTANCE DOCUMENT d844498d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 241018199
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)